POTED Human Pre-designed siRNA Set A contains three designed siRNAs for POTED gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POTEE Human Pre-designed siRNA Set A contains three designed siRNAs for POTEE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POTEF Human Pre-designed siRNA Set A contains three designed siRNAs for POTEF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POTEG Human Pre-designed siRNA Set A contains three designed siRNAs for POTEG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POTEI Human Pre-designed siRNA Set A contains three designed siRNAs for POTEI gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POTEJ Human Pre-designed siRNA Set A contains three designed siRNAs for POTEJ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU1F1 Human Pre-designed siRNA Set A contains three designed siRNAs for POU1F1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU2AF1 Human Pre-designed siRNA Set A contains three designed siRNAs for POU2AF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU2F1 Human Pre-designed siRNA Set A contains three designed siRNAs for POU2F1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU2F2 Human Pre-designed siRNA Set A contains three designed siRNAs for POU2F2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU2F3 Human Pre-designed siRNA Set A contains three designed siRNAs for POU2F3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU3F1 Human Pre-designed siRNA Set A contains three designed siRNAs for POU3F1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU3F2 Human Pre-designed siRNA Set A contains three designed siRNAs for POU3F2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU3F3 Human Pre-designed siRNA Set A contains three designed siRNAs for POU3F3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU3F4 Human Pre-designed siRNA Set A contains three designed siRNAs for POU3F4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU4F1 Human Pre-designed siRNA Set A contains three designed siRNAs for POU4F1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU4F2 Human Pre-designed siRNA Set A contains three designed siRNAs for POU4F2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU4F3 Human Pre-designed siRNA Set A contains three designed siRNAs for POU4F3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU5F1 Human Pre-designed siRNA Set A contains three designed siRNAs for POU5F1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pou5f1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pou5f1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pou5f1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Pou5f1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU5F1B Human Pre-designed siRNA Set A contains three designed siRNAs for POU5F1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU5F2 Human Pre-designed siRNA Set A contains three designed siRNAs for POU5F2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU6F1 Human Pre-designed siRNA Set A contains three designed siRNAs for POU6F1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POU6F2 Human Pre-designed siRNA Set A contains three designed siRNAs for POU6F2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POVPC is an oxidized phospholipid can be found in in oxidatively modified low density lipoprotein (oxLDL). POVPC inhibits VSMC growth in high serum condition. POVPC induces apoptosis in low serum condition[1].

Poziotinib (HM781-36B) is an orally active, irreversible pan-HER inhibitor, which effectively inhibits EGFRwt, HER-2 and HER-4 with IC50s of 3.2, 5.3 and 23.5 nM, respectively. Poziotinib (HM781-36B) also shows excellent inhibitory activities against mutated EGFRs, including EGFRT790M and EGFRL858R/T790M, with IC50s of 4.2 and 2.2 nM, respectively. Excellent antitumor activity[1][2].

Poziotinib (HM781-36B) is an orally active, irreversible pan-HER inhibitor, which effectively inhibits EGFRwt, HER-2 and HER-4 with IC50s of 3.2, 5.3 and 23.5 nM, respectively. Poziotinib (HM781-36B) also shows excellent inhibitory activities against mutated EGFRs, including EGFRT790M and EGFRL858R/T790M, with IC50s of 4.2 and 2.2 nM, respectively. Excellent antitumor activity[1][2].

Poziotinib (HM781-36B) is an orally active, irreversible pan-HER inhibitor, which effectively inhibits EGFRwt, HER-2 and HER-4 with IC50s of 3.2, 5.3 and 23.5 nM, respectively. Poziotinib (HM781-36B) also shows excellent inhibitory activities against mutated EGFRs, including EGFRT790M and EGFRL858R/T790M, with IC50s of 4.2 and 2.2 nM, respectively. Excellent antitumor activity[1][2].

Poziotinib (HM781-36B) is an orally active, irreversible pan-HER inhibitor, which effectively inhibits EGFRwt, HER-2 and HER-4 with IC50s of 3.2, 5.3 and 23.5 nM, respectively. Poziotinib (HM781-36B) also shows excellent inhibitory activities against mutated EGFRs, including EGFRT790M and EGFRL858R/T790M, with IC50s of 4.2 and 2.2 nM, respectively. Excellent antitumor activity[1][2].

Poziotinib (HM781-36B) is an orally active, irreversible pan-HER inhibitor, which effectively inhibits EGFRwt, HER-2 and HER-4 with IC50s of 3.2, 5.3 and 23.5 nM, respectively. Poziotinib (HM781-36B) also shows excellent inhibitory activities against mutated EGFRs, including EGFRT790M and EGFRL858R/T790M, with IC50s of 4.2 and 2.2 nM, respectively. Excellent antitumor activity[1][2].

PP487 is a dual inhibitor of tyrosine kinase/PI(3)Ks with IC50 values of 0.017 μM, 0.072 μM, 0.004 μM, 0.01 μM, 0.55 μM, 0.22 μM, and < 0.01 μM against DNA-PK, mTOR, Hck, Src, EGFR, EphB4, and PDGFR, respectively. PP487 can be used for cancer research[1].

PPA1 Human Pre-designed siRNA Set A contains three designed siRNAs for PPA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PPA2 Human Pre-designed siRNA Set A contains three designed siRNAs for PPA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PPAN Human Pre-designed siRNA Set A contains three designed siRNAs for PPAN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ppan Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ppan gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ppan Rat Pre-designed siRNA Set A contains three designed siRNAs for Ppan gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PPAR agonist 4 (Compound 12) is an orally active agonist for peroxisome proliferator-activated receptor (PPAR), which activates PPARα, PPARδ and PPARγ with EC50s of 0.7, 0.7 and 1.8 μM, respectively. PPAR agonist 4 exhibits anti-liver fibrosis efficacy[1].

PPARA Human Pre-designed siRNA Set A contains three designed siRNAs for PPARA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ppara Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ppara gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ppara Rat Pre-designed siRNA Set A contains three designed siRNAs for Ppara gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PPARD Human Pre-designed siRNA Set A contains three designed siRNAs for PPARD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ppard Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ppard gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ppard Rat Pre-designed siRNA Set A contains three designed siRNAs for Ppard gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.